Home > Insider Trading > Filing (0001062993-22-023905)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1267565	Collegium Pharmaceutical Inc	COLL	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1448914	Thomas Michael Heffernan	C/O Collegium Pharmaceutical, Inc. 100 Technology Center Drive Stoughton MA 02072		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-12-12	10,669	$14.90	38,692	No	4	M	Direct
Common Stock	Acquisiton	2022-12-12	15,741	$15.27	54,433	No	4	M	Direct
Common Stock	Acquisiton	2022-12-12	1,510	$14.57	55,943	No	4	M	Direct
Common Stock	Disposition	2022-12-12	27,920	$22.01	28,023	No	4	S	Direct
Common Stock	Acquisiton	2022-12-13	59,524	$14.90	87,547	No	4	M	Direct
Common Stock	Acquisiton	2022-12-13	94,259	$15.27	181,806	No	4	M	Direct
Common Stock	Acquisiton	2022-12-13	7,904	$14.57	189,710	No	4	M	Direct
Common Stock	Disposition	2022-12-13	161,687	$22.16	28,023	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Purchase)	Disposition	2022-12-12	10,669	$0.00	10,669	$14.90
Common Stock	Stock Option (Right to Purchase)t to	Disposition	2022-12-12	15,741	$0.00	15,741	$15.27
Common Stock	Stock Option (Right to Purchase)	Disposition	2022-12-12	1,510	$0.00	1,510	$14.57
Common Stock	Stock Option (Right to Purchase)	Disposition	2022-12-13	59,524	$0.00	59,524	$14.90
Common Stock	Stock Option (Right to Purchase)	Disposition	2022-12-13	94,259	$0.00	94,259	$15.27
Common Stock	Stock Option (Right to Purchase)	Disposition	2022-12-13	7,904	$0.00	7,904	$14.57

Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2025-05-14	No	4	M	Direct
2027-02-10	No	4	M	Direct
2029-04-25	No	4	M	Direct
2025-05-14	No	4	M	Direct
2027-02-10	No	4	M	Direct
2029-04-25	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2022.
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.00 to $22.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2).
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.00 to $22.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).
All of the 10,669 option shares are exercisable.
All of the 15,741 option shares are exercisable.
All of the 1,510 option shares are exercisable.
All of the 59,524 option shares are exercisable.
All of the 94,259 option shares are exercisable.
All of the 7,904 option shares are exercisable.